$HBAN

HBAN Maintains Buy Rating by UBS -- Price Target Lowered to $19.

UBS maintained a Buy rating on Huntington Bancshares (HBAN) but lowered its price target to $19.00 from $22.00, citing changing market conditions. According to GuruFocus, HBAN is 8.1% undervalued with a GF Value of $16.64. The company has a strong GF Score of 86/100, but insider activity shows significant selling.

Original reporting
Published Oct 5, 2026, 9:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 2:40 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$HBAN
Bearish
medium confidence
Mentioned
$HBAN
Relevance
6/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$HBANBearishMed
01

Why it matters

A reduced price target may lead to short‑term selling pressure, but the maintained Buy rating leaves room for upside.

02

Market read

The rating change is a modest catalyst for HBAN, with limited broader market impact.

03

What to watch

Insider selling is modest; the strong GF Score and growth rating may support a longer‑term buy.

Relevance 6/10Novelty 5/10Timing: today

Background

Analyst rating updates influence investor expectations and can move stock prices.

Company-level read

Ticker impact

$HBANBearishMedium confidence
Context

UBS lowered its price target for Huntington Bancshares to $19 from $22, maintaining a Buy rating.

Expected impact

likely pressure as the market prices in the lower target

Evidence & confidence

The downgrade reflects a more cautious outlook, which may temper bullish sentiment.

Market effects

Banking sector may see slight re‑rating as analysts adjust outlooks.

U.S. regional banks could experience modest sentiment shifts.

Limited to U.S. financial stocks.

Counterpoint

Despite the lower target, the stock remains undervalued at current price, offering upside.

Key entities

  • UBS

    Provided the rating update and new price target.

  • Huntington Bancshares

    Subject of the rating change.

Related articles

$HBANMed

Huntington Cut Its Outlook Right as the Fed Hiked. First Crack in Regional-Bank Margins?

Huntington Bancshares (HBAN) dropped 5.55% after lowering its 2027 EPS guidance to $1.75-$1.83 and 2026 net interest income growth to ~35%, citing rising deposit costs and loan pricing tightening. The Fed's rate hike exacerbated concerns about regional-bank margins, with peers like Fifth Third also seeing declines. Despite the selloff, Huntington's loan and deposit growth, along with fee income, provide some cushion. Analysts maintain an Overweight rating, with a price target of $21.

$JPMMed

Major U.S. banks raise prime rate after Fed rate hike

Major U.S. banks, including JPMorgan, Bank of America, and others, raised their prime lending rate to 7% after the Federal Reserve's quarter-point rate hike. The move increases borrowing costs for consumers and businesses. Bank stocks fell, with BofA down 2.7%, Citi 2.4%, and JPMorgan 1%. Rate hikes may boost bank earnings but could also slow economic activity and impact credit quality.

$HBANMed

Stocks fall after Federal Reserve raises interest rates

U.S. stocks fell Wednesday after the Federal Reserve raised interest rates, with the S&P 500 down 0.4% and the Dow Jones dropping 1.2%. Fed Chairman Kevin Warsh indicated more hikes may come as inflation remains high. Traders expect rates to reach 4.25%-4.50% by year-end. Bank stocks declined, while AI-related stocks like Nvidia and AMD rose.

$JPMMed

Major US banks raise prime rate after first Fed rate hike since 2023

Top U.S. banks, including JPMorgan and Bank of America, raised their prime lending rate to 7% after the Federal Reserve's first rate hike since 2023. The Fed increased rates by 0.25% and signaled further hikes, aiming to combat inflation. Bank shares fell, with JPMorgan down 1% and Goldman Sachs down 4%. Higher rates boost bank earnings but may slow economic activity and reduce loan demand.